Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of <scp>PD</scp>‐1 Inhibition as Potential Treatment Option

Immune Phenotypes in Patients With Invasive Mould Infection Support the Use of <scp>PD</scp>‐1 Inhibition as Potential Treatment Option

ABSTRACT Background Invasive mould infections (IMI) cause substantial morbidity and mortality in populations at risk. Novel treatment approaches are urgently needed. Targeting immune checkpoints may reverse hyporesponsiveness of the innate and adaptive immune systems. Methods In this prospective, ob...

Whakaahuatanga katoa

I tiakina i:

Ngā taipitopito rārangi puna kōrero
Ngā kaituhi matua:	Sibylle C. Mellinghoff, Martin Thelen, Michael von Bergwelt‐Baildon, Hans Schlößer, Oliver A. Cornely, Rosanne Sprute, Jannik Stemler, Leonie Mayer, Leonie M. Weskamm, Monika Friedrich, My Linh Ly, Christine Dahlke, Marylyn M. Addo
Hōputu:	Artigo
Reo:	Ingarihi
I whakaputaina:	2025
Urunga tuihono:	https://doi.org/10.1111/myc.70044
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite

SARS-CoV-2 specific cellular response following COVID-19 vaccination in patients with chronic lymphocytic leukemia
mā: Mellinghoff, Sibylle C., me ētahi atu.
I whakaputaina: (2021)

Antifungal prophylaxis and pre-emptive therapy: When and how?
mā: Rosanne Sprute, me ētahi atu.
I whakaputaina: (2023)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
mā: Koch, Till, me ētahi atu.
I whakaputaina: (2021)

Correlates of Vaccine-Induced Protection against SARS-CoV-2
mā: Till Koch, me ētahi atu.
I whakaputaina: (2021)

Persistence of MERS-CoV-spike-specific B cells and antibodies after late third immunization with the MVA-MERS-S vaccine
mā: Weskamm, Leonie M., me ētahi atu.
I whakaputaina: (2022)

<scp>OCTET</scp>‐<scp>CY</scp>: a phase <scp>II</scp> study to investigate the efficacy of post‐transplant cyclophosphamide as sole graft‐versus‐host prophylaxis after allogeneic peripheral blood stem cell transplantation
mā: Udo Holtick, me ētahi atu.
I whakaputaina: (2015)

<scp>T</scp>horacic<scp>S</scp>ociety of<scp>A</scp>ustralia and<scp>N</scp>ew<scp>Z</scp>ealand oxygen guidelines for acute oxygen use in adults: ‘Swimming between the flags’
mā: Richard Beasley, me ētahi atu.
I whakaputaina: (2015)

Case Report: Clinical Management of a Patient With Metastatic Non-Small Cell Lung Cancer Newly Receiving Immune Checkpoint Inhibition During Symptomatic COVID-19
mā: Mellinghoff, Sibylle C., me ētahi atu.
I whakaputaina: (2021)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
mā: Stemler, Jannik, me ētahi atu.
I whakaputaina: (2022)

Treatment of idiopathic pulmonary fibrosis in <scp>A</scp>ustralia and <scp>N</scp>ew Zealand: <scp>A</scp> position statement from the <scp>T</scp>horacic <scp>S</scp>ociety of <scp>A</scp>ustralia and <scp>N</scp>ew <scp>Z</scp>ealand and the <scp>L</scp>ung <scp>F</scp>oundation <scp>A</scp>ustralia
mā: Helen E. Jo, me ētahi atu.
I whakaputaina: (2017)

Personality Change Predicts Self‐Reported Mental and Physical <scp>H</scp>ealth
mā: Chris Magee, me ētahi atu.
I whakaputaina: (2012)

Bi‐functional transcription factor <scp>SlbHLH95</scp> regulates fruits flavonoid metabolism and grey mould resistance in tomato
mā: Dan Su, me ētahi atu.
I whakaputaina: (2025)

Comment on: Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching
mā: Grothe, Jan, me ētahi atu.
I whakaputaina: (2022)

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
mā: Giesen, Nicola, me ētahi atu.
I whakaputaina: (2021)

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
mā: Giesen, Nicola, me ētahi atu.
I whakaputaina: (2020)

2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy
mā: Nicola Giesen, me ētahi atu.
I whakaputaina: (2021)

Evidence-based management of COVID-19 in cancer patients: Guideline by the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)
mā: Nicola Giesen, me ētahi atu.
I whakaputaina: (2020)

<scp>CD</scp>161 expression characterizes a subpopulation of human regulatory <scp>T</scp> cells that produces <scp>IL</scp>‐17 in a <scp>STAT</scp>3‐dependent manner
mā: Behdad Afzali, me ētahi atu.
I whakaputaina: (2013)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
mā: Banck, Jan Christoph, me ētahi atu.
I whakaputaina: (2021)

Molecular role of the <scp>PAX</scp> 5‐ <scp>ETV</scp> 6 oncoprotein in promoting B‐cell acute lymphoblastic leukemia
mā: Leonie Smeenk, me ētahi atu.
I whakaputaina: (2017)

Comparing sensitivity and specificity of screening mammography in the <scp>U</scp>nited <scp>S</scp>tates and <scp>D</scp>enmark
mā: Katja Kemp Jacobsen, me ētahi atu.
I whakaputaina: (2015)

Distinct <i>in vivo</i> roles of secreted <scp>APP</scp> ectodomain variants <scp>APP</scp> sα and <scp>APP</scp> sβ in regulation of spine density, synaptic plasticity, and cognition
mā: Max Richter, me ētahi atu.
I whakaputaina: (2018)

EHA Endorsement of the Global Guideline for the Diagnosis and Management of Rare Mold Infection: An Initiative of the European Confederation of Medical Mycology in Cooperation With International Society for Human and Animal Mycology and American Society for Microbiology
mā: Sprute, Rosanne, me ētahi atu.
I whakaputaina: (2021)

<scp>RAC</scp>1 P29S regulates <scp>PD</scp>‐L1 expression in melanoma
mā: Ha Linh Vu, me ētahi atu.
I whakaputaina: (2015)

Both <scp>CRISPR</scp>/<scp>C</scp>as‐based nucleases and nickases can be used efficiently for genome engineering in <i><scp>A</scp>rabidopsis thaliana</i>
mā: Friedrich Fauser, me ētahi atu.
I whakaputaina: (2014)

Increased serum <scp>NfL</scp> and <scp>GFAP</scp> levels indicate different subtypes of neurologic immune‐related adverse events during treatment with immune checkpoint inhibitors
mā: Christina Schmitt, me ētahi atu.
I whakaputaina: (2025)

Evaluating the impact of community‐based treatment options on methamphetamine use: findings from the <scp>M</scp>ethamphetamine <scp>T</scp>reatment <scp>E</scp>valuation <scp>S</scp>tudy (<scp>MATES</scp>)
mā: Rebecca McKetin, me ētahi atu.
I whakaputaina: (2012)

Levodopa Impairs the Energy Metabolism of the Basal Ganglia <scp>In Vivo</scp>
mā: Jannik Prasuhn, me ētahi atu.
I whakaputaina: (2024)

The <i><scp>KIT</scp></i><scp>D</scp>816<scp>V</scp> allele burden predicts survival in patients with mastocytosis and correlates with the <scp>WHO</scp> type of the disease
mā: Gregor Hoermann, me ētahi atu.
I whakaputaina: (2014)

Surgical options for patients with <scp>L</scp>ennox‐<scp>G</scp>astaut syndrome
mā: Laurie M. Douglass, me ētahi atu.
I whakaputaina: (2014)

Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
mā: Badbaran, Anita, me ētahi atu.
I whakaputaina: (2021)

Pulmonary artery pressure‐guided therapy in ambulatory patients with symptomatic heart failure: the <scp>CardioMEMS E</scp>uropean <scp>M</scp>onitoring <scp>S</scp>tudy for <scp>H</scp>eart <scp>F</scp>ailure (<scp>MEMS‐HF</scp>)
mā: Christiane E. Angermann, me ētahi atu.
I whakaputaina: (2020)

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
mā: Piechotta, Vanessa, me ētahi atu.
I whakaputaina: (2022)

Effectiveness, immunogenicity, and safety of COVID-19 vaccines for individuals with hematological malignancies: a systematic review
mā: Vanessa Piechotta, me ētahi atu.
I whakaputaina: (2022)

S<scp>TRUCTURE</scp>, D<scp>YNAMICS</scp>, <scp>AND</scp> E<scp>NERGETICS OF THE</scp> P<scp>RIMARY</scp> P<scp>HOTOCHEMISTRY OF</scp> P<scp>HOTOSYSTEM</scp> II <scp>OF</scp> O<scp>XYGENIC</scp> P<scp>HOTOSYNTHESIS</scp>
mā: Bruce A. Diner, me ētahi atu.
I whakaputaina: (2002)

<scp>I</scp>nternational <scp>S</scp>ociety of <scp>N</scp>europathology‐<scp>H</scp>aarlem <scp>C</scp>onsensus <scp>G</scp>uidelines for <scp>N</scp>ervous <scp>S</scp>ystem <scp>T</scp>umor <scp>C</scp>lassification and <scp>G</scp>rading
mā: David N. Louis, me ētahi atu.
I whakaputaina: (2014)

O<scp>ral and</scp> P<scp>haryngeal</scp> R<scp>eflexes in the</scp> M<scp>ammalian</scp> N<scp>ervous</scp> S<scp>ystem:</scp> T<scp>heir</scp> D<scp>iverse</scp> R<scp>ange in</scp> C<scp>omplexity and the</scp> P<scp>ivotal</scp> R<scp>ole of the</scp> T<scp>ongue</scp>
mā: Arthur J. Miller
I whakaputaina: (2002)

T<scp>he </scp>U<scp>se of </scp>E<scp>namel </scp>M<scp>atrix </scp>D<scp>erivative in the </scp>T<scp>reatment of </scp>P<scp>eriodontal </scp>D<scp>efects</scp>: <scp>a </scp>L<scp>iterature </scp>R<scp>eview and </scp>M<scp>eta</scp>-<scp>analysis</scp>
mā: Eyal Venezia, me ētahi atu.
I whakaputaina: (2004)

<scp>N</scp>on‐<scp>D</scp>estructive <scp>D</scp>etermination of <scp>M</scp>uscle <scp>A</scp>rchitectural <scp>V</scp>ariables <scp>T</scp>hrough the <scp>U</scp>se of <scp>D</scp>ice<scp>CT</scp>
mā: Edwin Dickinson, me ētahi atu.
I whakaputaina: (2018)

T<scp>ESTS OF</scp>R<scp>EPRODUCTIVE</scp>-S<scp>KEW</scp>M<scp>ODELS IN</scp>S<scp>OCIAL</scp>I<scp>NSECTS</scp>
mā: H. Kern Reeve, me ētahi atu.
I whakaputaina: (2001)